Search Results - david+eisenberg

4 Results Sort By:
Compounds that Disaggregate Alzheimer's Disease-Associated Fibrils of Tau Protein (UCLA Case No. 2022-145, 2025-329)
UCLA researchers in the Department of Biological Chemistry, Chemistry and Biochemistry developed a new tau-inhibiting seven residue peptide and conjugated it to magnetic nanoparticles for the treatment of Alzheimer’s disease. These compounds disaggregate pathogenic tau amyloid fibrils at atomic resolution, restore normal neuronal function, and...
Published: 11/19/2025   |   Inventor(s): David Eisenberg, Ke Hou
Keywords(s):  
Category(s): Therapeutics > CNS and Neurology
Nitrogen-doped graphene-rich carbon materials for technological applications
This invention describes a low-temperature pyrolysis method to produce graphene-rich carbon materials using hexagonal metal oxides as templates. The process prevents graphene stacking into graphite and allows nitrogen doping, enhancing properties for applications like electrodes and catalysts. Background Graphene, a single layer of carbon atoms arranged...
Published: 11/25/2025   |   Inventor(s): Adam Heller, Keith Friedman, Sheryl Coffman, David Eisenberg, Joo-Woon Lee
Keywords(s):  
Category(s): Life sciences > Medical technology > Medical devices
2019-701 PEPTIDE-BASED INHIBITORS THAT BLOCK AGGREGATION, SEEDING AND CROSS-SEEDING OF AMYLOID BETA AND TAU
UCLA researchers in the Department of Chemistry and Biochemistry have developed novel therapeutics for Alzhiemer’s Disease and other tauoapathies. BACKGROUND:Alzhiemer’s Disease (AD) is a severe neurodegenerative disease characterized by deterioration of the brain cells and loss of multiple cognitive functions. Although AD is the most...
Published: 7/17/2025   |   Inventor(s): David Eisenberg, Paul Seidler
Keywords(s): Cns, Therapeutics & Vaccines
Category(s): Therapeutics > CNS and Neurology
2016-694 INHIBITION OF THE AGGREGATION OF TRANSTHYRETIN BY SPECIFIC BINDING OF PEPTIDES TO AGGREGATION-DRIVING SEGMENTS
Inhibition of the Aggregation of Transthyretin by Specific Binding of Peptides to Aggregation-Driving SegmentsSUMMARYUCLA researchers from the Department of Chemistry and Biochemistry have developed a novel process to inhibit amyloid aggregation of Transthyretin, which is associated with three debilitating disorders including senile systemic amyloidosis...
Published: 7/17/2025   |   Inventor(s): David Eisenberg, Lorena Saelices Gomez
Keywords(s): Cardiovascular, Cns, Genetic Disease, Hematology, Therapeutics & Vaccines
Category(s): Therapeutics, Therapeutics > Cardiovascular, Therapeutics > Hematology, Therapeutics > CNS and Neurology